Sankala Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Buy
17,211
+12,314
+251% +$150K 0.14% 140
2026
Q1
$68.9K Buy
4,897
+3,157
+181% +$44.3K 0.06% 205
2025
Q4
$24.5K Buy
+1,740
New +$26.2K 0.02% 295

Other funds holding BTAL

Sankala Group's BTAL Position: Q2 2026 in Review

Sankala Group increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 251% in Q2 2026, buying an estimated $150K and bringing the position to 17,211 shares worth $209K. The position accounts for 0.14% of the portfolio, ranked #140.

Sankala Group first reported a position in BTAL in Q4 2025 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Sankala Group held 17,211 shares of AGF US Market Neutral Anti-Beta Fund worth $209K as of Q2 2026.
  • Sankala Group bought 12,314 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $150K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.14% of Sankala Group's portfolio in Q2 2026, its #140 holding.
  • Sankala Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2025 and has held it in 3 quarters since.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.